StockPulse is a software subscription service that translates and summarizes U.S. stock filings and news into alerts. It is not an investment advisory, brokerage, or discretionary management service.

All information provided (filing summaries, price data, keywords, etc.) is processed from public sources for reference only and is not a recommendation to buy or sell any security. Investment decisions and their outcomes are the sole responsibility of the user.

노마드랩 주식회사 · 대표 황승준 · 사업자등록번호 588-81-01342

부산광역시 해운대구 센텀중앙로 55, 9층 7호(우동)

통신판매업 제2026-부산해운대-0983호 · 문의  

고객문의 070-4268-1176

App Store▶ Google Play
GuideFAQWeeklyTerms of ServicePrivacy PolicyPayment & Refund Policy

StockPulse · 스탁펄스(스톡펄스) — 미국주식 공시·뉴스 실시간 알림

© 2026 노마드랩 주식회사. All rights reserved.

StockPulseStockPulseFeedReportMacro·SectorsCommunityAlertsMy
Theme
FeedReportMacro·SectorsCommunityAlertsMy
CSBRCHAMPIONS ONCOLOGY, INC.
stockpulse.co.kr
Nasdaq
$4.72▲ 1.51%vs prev close
🔒 Quotes & buy pressure are MAX onlySee plans
Market cap $65.5MShares out 13.9M sh
At a glance🔒 At-a-glance is MAX onlySee plans

Chart

Filings & news by date

Hover (PC) or tap (mobile) a candle to see that day only

🔒 Members only
Live tape🔒 Live tape is MAX onlySee plans

Filings

8
  • 10.16Regular26.10.17 01:45
    4Ownership#●●●

    CHAMPIONS ONCOLOGY, INC.

    Insider Joel Ackerman of Champions Oncology, Inc. filed a Form 4 statement of changes in beneficial ownership of securities on October 15, 2026. This filing serves as a formal report regarding the insider's change in equity holdings.…more

    $4.72+1.51%vs prev closeDetected5m · 30m · 60m · Next dayPLUS
    View filingShare
  • 10.16Regular26.10.17 01:15
    8-KKey event

    CHAMPIONS ONCOLOGY, INC.

    Champions Oncology, Inc. held its 2026 Annual Meeting of Stockholders on October 14, 2026, where all proposed items including the election of directors, ratification of the independent accounting firm, and approval of the 2026 Equity Incentive Plan were passed. Following the advisory vote, the company intends to hold future advisory votes on executive compensation on an annual basis.…more

    $4.72+1.51%vs prev close
    View filingShare
  • 9.11Regular26.09.12 03:51
    10-QEarnings

    CHAMPIONS ONCOLOGY, INC.

    Champions Oncology (CSBR) reported revenue of $15.23 million for the first quarter of fiscal year 2027, ending July 31, 2026, showing growth compared to the same period last year. However, the company recorded a net loss of $426,000, continuing its loss-making trend from the $466,000 net loss reported in the prior year's quarter due to increased operating expenses.…more

    $4.72+1.51%vs prev close
    View filingShare

7 more filings

Sign up free to unlock the full feed and real-time filing & news alerts.

  • ✓Free — no card required
  • ✓Full real-time filing & news feed
  • ✓Daily Today Report
Sign up free & see allPreview the Today Report →

News

GlobeNewswire
  • 9.10After-hours26.09.11 05:26
    Bullish#●●●#●●●

    Champions Oncology Reports Q1 Revenue and EPS Growth

    Champions Oncology reported Q1 revenue of $15.232 million and an EPS of $0.05, showing growth compared to the same period last year. The company demonstrated solid performance with improvements in both revenue and profitability.…more

    $4.72+1.51%vs prev closeDetected5m · 30m · 60m · Next dayPLUS
    ShareBenzinga
  • 9.1Pre-market26.09.01 22:05

    ●●●●●●●● ●●●●● ●●●●●●

    Champions Oncology has integrated in-house SPECT/CT imaging capabilities into its radiopharmaceutical development platform to enhance tumor biology and efficacy insights. This expansion allows researchers to longitudinally track radiopharmaceutical uptake and correlate it with therapeutic responses in clinically annotated tumor models.…more

    $4.72+1.51%vs prev close
    ShareBenzinga

1 more news items

Sign up free to unlock the full feed and real-time filing & news alerts.

  • ✓Free — no card required
  • ✓Full real-time filing & news feed
  • ✓Daily Today Report
Sign up free & see allPreview the Today Report →